WHO khuyến nghị tiếp tục tiêm vaccine AstraZeneca ngừa COVID-19

Ngày 15/3, Tổ chức Y tế Thế giới (WHO) cho biết nhóm cố vấn của cơ quan y tế lớn nhất thế giới này đang xem xét lại các báo cáo liên quan đến vaccine ngừa COVID-19 của AstraZeneca tuy chưa có bằng chứng cho thấy việc tiêm vaccine này gây ra bất kỳ sự cố nào đối với sức khỏe.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Chi phí xung đột Israel - Iran vượt 11 tỷ USD

Chi phí xung đột Israel - Iran vượt 11 tỷ USD

Thế giới
(Baothanhhoa.vn) - Theo thông báo của Bộ Tài chính Israel, chi phí từ xung đột giữa Israel và Iran đang gia tăng nhanh chóng, với ước tính chi phí trực tiếp từ xung đột với Iran kể từ cuối tháng 2/2026 đã lên tới khoảng 35 tỷ shekel (tương đương 11,5 tỷ USD).
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh